Simple math illustrates the challenge facing U.S. taxpayers, consumers and insurers following the launch late last year of two expensive new drugs to treat hepatitis C. If all 3 million people ...

WASHINGTON (AP) The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors. The new leading pill for hepatitis C is more ...

(Reuters) - Merck & Co's recently approved Victrelis treatment for hepatitis C considerably lessens the effectiveness of some widely used medicines against the virus that causes AIDS, Merck and U.S.

March 10 (Reuters) - Highly effective but expensive new pills to treat hepatitis C drove a 13.1 percent increase U.S. prescription drug spending in 2014, the fastest rate of increase in more than a ...

The recently approved drug to treat Hepatitis C comes with a hefty price tag. Foster City, Calif.-based Gilead Sciences’s Sovaldi received approval in December from the U.S. Food and Drug ...

Sovaldi has been found to be remarkably effective in curing most patients with common forms of hepatitis C in a matter of months. But the clinical... The launch of Sovaldi, the $1,000-a-day pill for ...

There's a new, revolutionary Hepatitis C pill on the market; it has a short treatment time and fewer side effects than its predecessors. Sovaldi earned the distinction of being called a "breakthrough ...

WASHINGTON (AP) — Federal health officials have approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the ...

According to the Centers for Disease Control and Prevention, more than 2 million people in the U.S. are infected with hepatitis C. The bloodborne illness attacks the liver and can lead to cancer or ...

The FDA has greenlit its first point-of-care diagnostic test for hepatitis C, capable of using only a fingerstick blood sample, in a bid to quickly connect patients with antiviral drugs. “Despite the ...